Sign In

Thomas D. Schmittgen PhD

Thomas D. Schmittgen PhD
Assoc ProfessorCollege of Pharmacyschmittgen.2@osu.edu
536 Parks Hall 500 W 12th Avenue Columbus OH 43210
Phone:614-292-3456Fax: 614-292-7766
  • Experimental Therapeutics

Current Publications

  • McNally ME, Collins A, Wojcik SE, Liu J, Henry JC, Jiang J, Schmittgen T, Bloomston MConcomitant dysregulation of microRNAs miR-151-3p and miR-126 correlates with improved survival in resected cholangiocarcinoma.HPB (Oxford) 15(4) 260-4 4/1/2013
  • Park JK, Kogure T, Nuovo GJ, Jiang J, He L, Kim JH, Phelps MA, Papenfuss TL, Croce CM, Patel T, Schmittgen TDmiR-221 silencing blocks hepatocellular carcinoma and promotes survival.Cancer Res 71(24) 7608-16 12/15/2011
  • Henry JC, Azevedo-Pouly AC, Schmittgen TDMicroRNA replacement therapy for cancer.Pharm Res 28(12) 3030-42 12/1/2011